Loading clinical trials...
Loading clinical trials...
A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiac Surgery With Cardiopulmonary Bypass
Conditions
Interventions
AT-III (Human)
Placebo
Locations
41
United States
UC Irvine
Orange, California, United States
VA Medical Center - San Francisco
San Francisco, California, United States
Stanford University Hospital and Clinics
Stanford, California, United States
University of Colorado
Aurora, Colorado, United States
Yale University School of Medicine
New Haven, Connecticut, United States
University of Florida College of Medicine
Gainesville, Florida, United States
Start Date
June 26, 2014
Primary Completion Date
January 25, 2018
Completion Date
January 25, 2018
Last Updated
March 15, 2019
NCT07418242
NCT05573633
NCT07287345
NCT06474754
NCT06986187
NCT05879432
Lead Sponsor
Grifols Therapeutics LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions